Zoetis Inc. (ZTS), the global leader in animal health, is generating significant interest among investors and shareholders alike. Entities such as
Swmg LLC and
R Squared Ltd have recently made notable investments in the company worth $265,000 and $248,000 respectively. The company is seeing its stock trading differently, making minor movements of -0.12%. A bullish case is being set for ZTS, with 15,000 shares recently acquired by
Sivik Global Healthcare LLC. Multiple firms have increased their holdings, including
New England Research & Management Inc.,
Pacer Advisors Inc., and
Swedbank AB. Questions were raised about the company's use of debt and valuation; however, Zoetis’ return on equity (ROE) has been high, outperforming its industry. Despite Morgan Stanley lowering the price target from $248 to $243, ZTS remains a top choice for investors studying long-term growth stocks. Zoetis recently boosted its quarterly dividend by 16% to a record $0.50, reflecting its robust financial performance. Furthermore, the firm has made significant strides toward global growth strategy, reshaping its leadership and creating a new CCO role. The company has been maintaining a favorable outlook and taking strategic initiatives, such as the declaration of its first quarter 2025 dividend.
Zoetis ZTS News Analytics from Thu, 19 Sep 2024 07:00:00 GMT to Sat, 01 Feb 2025 14:46:36 GMT -
Rating 7
- Innovation 5
- Information 8
- Rumor 2
